← FDA DRUG APPROVALS

FDA ANDA · ANDA087209

AMINOPHYLLINE

Sponsor: INTL MEDICATION

APPLICATION
ANDA087209
TYPE
ANDA
ORIGINAL APPROVAL
1982-02-01
LATEST ACTION
1995-09-19
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

AMINOPHYLLINEDiscontinued
AMINOPHYLLINE 25MG/ML · INJECTABLE · INJECTION

Approval history

1995-09-19Manufacturing (CMC) · Supplement 12AP
1994-06-17Manufacturing (CMC) · Supplement 11AP
1991-03-26Labeling · Supplement 6AP
1987-05-01Manufacturing (CMC) · Supplement 4AP
1986-12-04Manufacturing (CMC) · Supplement 3AP
1982-02-01OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →